Viewing Study NCT06577818



Ignite Creation Date: 2024-10-26 @ 3:39 PM
Last Modification Date: 2024-10-26 @ 3:39 PM
Study NCT ID: NCT06577818
Status: NOT_YET_RECRUITING
Last Update Posted: None
First Post: 2024-08-27

Brief Title: Sustained Inflation and Chest Compression vs 31 CV Ratio in Asphyxiated Newborns
Sponsor: None
Organization: None

Study Overview

Official Title: Sustained Inflation and Chest Compression Versus 31 Chest Compression to Ventilation Ratio During Cardiopulmonary Resuscitation of Asphyxiated Newborns - a Multi-centre International Cluster Randomized Control Trial
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: SUR1VE-2
Brief Summary: Newborn infants who require cardiopulmonary resuscitation at birth receive chest compression using a 3-Compression to 1-Ventilation 31 CV ratio However the optimal chest compression technique during cardiopulmonary resuscitation is uncertain and identified as a critical gap in evidence The International Consensus Statement advises to use the 31 CV ratio based on animal studies and states that there are no clinical trials to support this approach and called for more research There continues to be uncertainty about the optimal chest compression technique during cardiopulmonary resuscitation

This trial will compare if in newborn infants with cardiac arrest in the delivery room does providing CCSI a new chest compression technique compared to 31 CV decreases the incidence of mortality at hospital discharge

This will be a multi-centre international cluster randomized trial
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None